Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 2,173-2,184 of 10,612

Drug study icon

CompletedNCT02511886

A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Addiction

This study is completed in the United States. It focuses on Addiction.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Indivior Inc.
Condition: Addiction

Drug study icon

CompletedNCT05407064

A Dose-Finding Study of MM120 (LSD D-Tartrate) for Anxiety Symptoms

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AnxietyDrugFrom 18 Years to 74 Years

Countries: United States
Sponsor: Definium Therapeutics US, Inc.
Condition: Anxiety

Drug study icon

CompletedNCT00429091

A Study of the Efficacy of ABT-894 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Abbott
Condition: ADHD

Drug study icon

CompletedNCT00391729

A Cross-over Study of the Safety and Efficacy of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Abbott
Condition: ADHD

Behavioral study icon

Active Not RecruitingNCT04175041

A Dose-Response Study of the Cognitive and Physiological Effects of tDCS to the DLPFC

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT01996644

A Double Blind study of DCS for Food Anxiety

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disorders, AnxietyDrugFrom 14 Years to 65 Years

Countries: United States
Sponsor: Washington University School of Medicine
Condition: Eating disorders, Anxiety

Drug study icon

TerminatedNCT00584688

A Double Blind, Placebo Controlled study of Quetiapine in Eating disorders, a Dual Site Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: University of South Florida
Condition: Eating disorders

Drug study icon

CompletedNCT00181571

A Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT00181675

A Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 18 Years to 58 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

TerminatedNCT01721330

A Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder

This study was terminated in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: ADHD

Drug study icon

CompletedNCT00376220

A Placebo Controlled study of Riluzole in Depression in bipolarity

This study is completed in the United States. It is testing Double-Blind Placebo Controlled Trial of Riluzole for depression in bipolarity.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Johns Hopkins University
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT00232414

Quetiapine for depression

This study is completed in the United States. It is testing quetiapine for depression.

In United States

Bipolarity, DepressionDrugFrom 12 Years to 18 Years

Countries: United States
Sponsor: University of Cincinnati
Condition: Bipolarity, Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.